CRISPR-based COVID-19 surveillance using a genomically-comprehensive machine learning approach
Metsky, H. C.; Freije, C. A.; Kosoko-Thoroddsen, T.-S. F.; Sabeti, P. C.; Myhrvold, C.
Show abstract
The emergence and outbreak of SARS-CoV-2, the causative agent of COVID-19, has rapidly become a global concern and has highlighted the need for fast, sensitive, and specific tools to surveil circulating viruses. Here we provide assay designs and experimental resources, for use with CRISPR-based nucleic acid detection, that could be valuable for ongoing surveillance. We provide assay designs for detection of 67 viral species and subspecies, including: SARS-CoV-2, phylogenetically-related viruses, and viruses with similar clinical presentation. The designs are outputs of algorithms that we are developing for rapidly designing nucleic acid detection assays that are comprehensive across genomic diversity and predicted to be highly sensitive and specific. Of our design set, we experimentally screened 4 SARS-CoV-2 designs with a CRISPR-Cas13 detection system and then extensively tested the highest-performing SARS-CoV-2 assay. We demonstrate the sensitivity and speed of this assay using synthetic targets with fluorescent and lateral flow detection. Moreover, our provided protocol can be extended for testing the other 66 provided designs. Assay designs are available at https://adapt.sabetilab.org/.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Utility of Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics 92%
- Surveillance and correlation of SARS-CoV-2 viral RNA, antigen, virus isolation, and self-reported symptoms in a longitudinal study with daily sampling 91%
- Repeat COVID-19 Molecular Testing: Correlation with Recovery of Infectious Virus, Molecular Assay Cycle Thresholds, and Analytical Sensitivity 90%
Similar papers in this journal
- Development and Implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities 93%
- Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery 93%
- Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.